Cargando…

Sexual Dysfunction in Males with Hepatitis C Virus: Relevance to Histopathologic Changes and Peginterferon Treatment

BACKGROUND/AIM: The frequency of sexual dysfunction (SD) is not well known in patients with chronic hepatitis C virus (HCV). In spite of the fact that histological benefits of peginterferon (Peg-IFN)/ribavirin therapy are well established, the effects on sexual health are less certain. To assess the...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Atrebi, Kamal A., El-Atrebi, Mohamed A., El-Bassyouni, Hala T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221116/ https://www.ncbi.nlm.nih.gov/pubmed/22064340 http://dx.doi.org/10.4103/1319-3767.87183

Ejemplares similares

Management of rare side effects of peginterferon and ribavirin therapy during hepatitis C treatment: a case report
por: EL-Atrebi, Kamal, et al.
Publicado: (2009)

Efficacy and safety of intradetrusor onabotulinumtoxinA injection for managing paediatric non-neurogenic overactive bladder: A prospective case-series study
por: El-Dakhakhny, Amr S., et al.
Publicado: (2019)

Effect of tramadol dependence on male sexual dysfunction
por: KABBASH, Abdelmoty, et al.
Publicado: (2019)

Indicators of the metabolic syndrome in obese adolescents
por: Zaki, Moushira Erfan, et al.
Publicado: (2015)

Inflammatory and endothelial dysfunction indices among Egyptian females with obesity classes I–III
por: Mohamed, Amal Ahmed, et al.
Publicado: (2020)

Elasomeran/peginterferon: Autoimmune hepatitis: case report
Publicado: (2022)

Potential impact of gut Lactobacillus acidophilus and Bifidobacterium bifidum on hepatic histopathological changes in non-cirrhotic hepatitis C virus patients with different viral load
por: Ashour, Zeinab, et al.
Publicado: (2022)

Association of serum paraoxonase enzyme activity and oxidative stress markers with dyslipidemia in obese adolescents
por: Zaki, Moushira Erfan, et al.
Publicado: (2014)

Efficacy and Tolerability of Peginterferon alpha-2a and Peginterferon alpha-2b in Iranian Patients With Chronic Hepatitis C
por: Pouresmaeeli, Mahdiyar, et al.
Publicado: (2015)

The Effect of Peginterferon Alpha-2a vs. Peginterferon Alpha-2b in Treatment of Naive Chronic HCV Genotype-4 Patients: A Single Centre Egyptian Study
por: El Raziky, Maissa, et al.
Publicado: (2013)

Predictors of male sexual dysfunction in post traumatic stress disorder
por: Maalej, R., et al.
Publicado: (2021)

Peginterferon based therapy for chronic hepatitis C in the elderly patients
por: Bold, Adriana, et al.
Publicado: (2013)

Peginterferon alpha and ribavirin combination therapy in patients with hepatitis C virus-related liver cirrhosis
por: Kim, Kyung Hoon, et al.
Publicado: (2011)

Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa
por: Liu, Chen-Hua, et al.
Publicado: (2014)

Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus
por: Grando, Aline Vitali, et al.
Publicado: (2017)

Serum hepatitis B virus RNA predicts response to peginterferon treatment in HBeAg‐positive chronic hepatitis B
por: van Campenhout, Margo J. H., et al.
Publicado: (2020)

Incidence of and risk factors for thyroid dysfunction during peginterferon α and ribavirin treatment in patients with chronic hepatitis C
por: Hwang, Yong, et al.
Publicado: (2015)

Polyploidy in chronic lymphocytic leukemia with p53 deletion detected by fish: a case report
por: Eid, Maha, et al.
Publicado: (2009)

Mechanisms and histopathological impacts of acetamiprid and azoxystrobin in male rats
por: EL-Hak, Heba Nageh Gad, et al.
Publicado: (2022)

Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a
por: El-Lababidi, Rania M., et al.
Publicado: (2020)

Serum soluble receptor of advanced glycation end products and risk of metabolic syndrome in Egyptian obese women
por: Zaki, Moushira, et al.
Publicado: (2017)

Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?
por: Jung, Young Kul, et al.
Publicado: (2013)

Biphasic calcium phosphate doped with zirconia nanoparticles for reconstruction of induced mandibular defects in dogs: cone-beam computed tomographic and histopathologic evaluation
por: Taha, Said K., et al.
Publicado: (2023)

Piroxicam-induced hepatic and renal histopathological changes in mice
por: Ebaid, Hossam, et al.
Publicado: (2007)

Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus
por: Kim, Yu Jin, et al.
Publicado: (2011)

Serum cystatin C is an early renal dysfunction biomarker in patients with hepatitis C virus
por: Assem, Nagwa Mohamed, et al.
Publicado: (2022)

Association of vitamin D receptor gene polymorphism (VDR) with vitamin D deficiency, metabolic and inflammatory markers in Egyptian obese women
por: Zaki, Moushira, et al.
Publicado: (2017)

Pros and Cons of Peginterferon Versus Nucleos(t)ide Analogues for Treatment of Chronic Hepatitis B
por: Sonneveld, Milan J., et al.
Publicado: (2010)

Evaluation of DNA damage profile in obese women and its association to risk of metabolic syndrome, polycystic ovary syndrome and recurrent preeclampsia
por: Zaki, Moushira, et al.
Publicado: (2018)

Sperm quality and testicular histopathology of Wistar albino male rats treated with hydroethanolic extract of Cordia dichotoma fruits
por: El-Newary, Samah A., et al.
Publicado: (2022)

Cost-Efficacy Analysis of Peginterferon alfa-2b plus Ribavirin Compared With Peginterferon alfa-2a plus Ribavirin for the Treatment of Chronic Hepatitis C
por: Malone, Daniel C., et al.
Publicado: (2005)

Population pharmacokinetics of peginterferon α2a in patients with chronic hepatitis B
por: Bi, Jingfeng, et al.
Publicado: (2017)

Expression Pattern of Cytokines in Patients with Chronic Hepatitis B Receiving PEGinterferon Therapy
por: Chen, Shao-Long, et al.
Publicado: (2023)

Association of the Pro12Ala Polymorphism with the Metabolic Parameters in Women with Polycystic Ovary Syndrome
por: Zaki, Moushira, et al.
Publicado: (2017)

Clinical Pharmacokinetic Evaluation of Optimized Liquisolid Tablets as a Potential Therapy for Male Sexual Dysfunction
por: Alotaibi, Fayez O., et al.
Publicado: (2020)

Histopathological changes of organ dysfunction in sepsis
por: Garofalo, Antonio M., et al.
Publicado: (2019)

A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C
por: Flisiak, Robert, et al.
Publicado: (2016)

A cephalometric study of skulls from the Bahriyah oasis
por: Zaki, Moushira Erfan, et al.
Publicado: (2012)

Long-term effects of peginterferon alfa-2a therapy in Japanese patients with chronic hepatitis B virus infection
por: Masaki, Keiichi, et al.
Publicado: (2015)

Simeprevir with peginterferon/ribavirin for patients with hepatitis C virus genotype 1: high frequency of viral relapse in elderly patients
por: Watanabe, Takao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6hefdici888v44dl3j1ncrfipi